Adverse drug reactions to second-generation antihistamines in children
Whilst it is known first-generation antihistamines can cause somnolescence in a large proportion of patients, it was generally thought that second-generation antihistamines had fewer side effects. 1
Many children are prescribed systemic antihistamines, which are used for the treatment of allergic rhinitis, chronic spontaneous urticaria, atopic eczema, and allergic conjunctivitis. 1
Authors De Vries and van Hunsel studied the safety profile of second-generation anti histamines in order to inform prescribing physicians of relevant adverse drug reactions (ADRs). 1
The authors retrospectively studied reports of ADRs in children (0–18 years) taking systemic antihistamines made to the Netherlands Pharmacovigilance Centre Lareb between 1991 and 2014. 1
Over the 24-year study period, there were 228 relevant reports of ADRs to the Netherlands Pharmacovigilance Centre Lareb, of which five were considered serious. 1
Skin eruptions and headaches were the most frequently reported ADRs to antihistamines. 1
In addition, problems associated with the central nervous system were also reported, including: 1
- Aggression
- Hyperactivity
- Agitation
- Somnolescence
- Seizures.
A strength of this study is that all paediatric ADR reports on systemic antihistamines in the Netherlands Pharmacovigilance Centre Lareb Database were included. 1Using a voluntary spontaneous reporting database means that reporting will occur only when correlation of a drug to the reported ADR is suspected. 1However, the causality is not always certain. 1
The authors concluded that physicians should be aware of these possible ADRs when prescribing second-generation antihistamines. 1